How digital healthcare tools are changing medicine in Europe since COVID-19

Like in America, the healthcare industry is also making shifts to adopt new, safer hospital practices in response to Covid-19. Since physical contact and proximity present such risks, hospitals are turning to a variety of digital tools in order to meet their care priorities, such as risk reduction and better resource utilization. Having a better understanding of these priorities and what tools hospitals are using now will help us in the health tech industry know what to build for them next.

At Siilo, we believe that putting tried and true technology into the hands of healthcare professionals will result in a higher quality of care for patients down the line. Here are the three major categories of care currently being aided by digital tools: distance diagnoses, internal communications, and external collaborations.

Distance diagnoses
Covid-19 was not the start of the telehealth revolution, but it was certainly a major driver in its widespread adoption this year. While doctors and specialists could not and still cannot see their patients in person, that doesn’t mean people haven’t stopped needing consultations. Moving diagnoses online has been the only option to continue delivering care directly to patients.

Companies like Germany’s Klara are working to put these digital tools at the center of doctor-patient communication all across Europe. Telehealth services provide a variety of benefits: anything from patient portals, where individuals can email their doctors in a secure online environment, to mobile applications, allowing doctors to hold virtual appointments with patients via video call. They can also include the collection of health data, voluntarily given by patients, through the Internet of Things, such as smartwatches, in order to get a more holistic view of the patient’s wellbeing.

Advances in telehealth can certainly ease the burdens on healthcare professionals looking to safely diagnose their patients over digital platforms, but we need to make sure that we are providing products that prioritize data safety. That means designing for GDPR compliance incorporating key features, like passcode protection and device-only data storage.

Internal Communications
The influx of telehealth and digital solutions for communicating with patients has also resulted in a professional counterpart for members of medical institutions, organizations, and associations all across Europe. Beyond the EHRs and secure email servers typically found in hospitals or physicians’ offices, technology is being developed to make communication by modern healthcare professionals more efficient, more secure, and more informative.

People bring their smartphones to work with them, and as such, we see professionals increasingly seeking out mobile tools and applications to simplify their workflows. In particular, professionals are looking for ways to quickly exchange information with each other and their departments at large. My company, Siilo works in this space.

This integration is not seamless, however. Bring-your-own-device policies, such as those found in Germany and France, have been put in place to limit the chances of cross-contaminating patient data and personal information, and increasing digital literacy amongst professionals can be a difficult and time-consuming endeavor. Nevertheless, hospitals and public health institutions should be prepared

Read more

Why Is Europe Keeping Its Schools Open, Despite New Lockdowns?

BERLIN — When Chancellor Angela Merkel announced the latest round of restrictions on public life, she named bars, restaurants, theaters, concert halls, gyms and tattoo parlors as institutions that would be forced to close. But missing from the list released on Wednesday were schools and day care centers — among the first to be shuttered in the spring lockdown.

In France, President Emmanuel Macron also said on Wednesday that schools would be exempt from wide-reaching nationwide restrictions that are to take effect beginning Friday. Ireland also allowed schools to remain open despite a nationwide lockdown that went into effect earlier this month.

Not everyone is happy with the decisions, but policymakers are taking extra precautions to reduce the risk in schools, from mask requirements for teachers and pupils, to regular airing of classrooms, to split use of schoolyards during breaks. They say they are applying hard-learned lessons from months of fighting the pandemic, and are prepared to change directions if things take a turn for the worse.

Micheal Martin, the Irish prime minister, said that while his country could no longer avoid restrictions, despite the detrimental impact on the economy, it was vital that schools remained open.

“We cannot and will not allow our children and young people’s futures to be another victim of this disease,” Mr. Martin said in a national address. “They need their education.”

Around the world, there is mounting concern that the pandemic is doing lasting harm to the academic and emotional development of an entire generation of children.

Earlier this month, the German conference of ministers of culture, who are responsible for coordinating education policy, stressed children’s right to an education, which they said is best served among peers, in classrooms. “This must take highest priority in making all decisions about restrictive measures that need to be taken,” the minister said.

In making her announcement, Ms. Merkel cited another reason that maintaining access to schools was important, pointing to the “dramatic social consequences” that closing schools and day care centers had on families during the lockdown in March and April.

“To name it clearly: Violent assaults against women and children increased dramatically,” Ms. Merkel said, justifying her government’s decision to halt sports, cultural events and close restaurants instead. “It is important to bear in mind the social consequences if we have to intervene in these issues.”

Keeping children at home often made it hard for parents — especially mothers — to devote their divided attention to work.

Medical experts point to many things they now know that were unknown back in the spring: with proper precautions, the rate of coronavirus transmission in schools is relatively low, especially among the youngest students; children who do get infected tend to have mild symptoms; and measures like mask-wearing, social distancing and air circulation are more effective than they had predicted.

But that does not mean open schools are risk-free. While schools are not known to have been a major

Read more

Europe ‘At Epicentre’ of Pandemic Again



These are the UK coronavirus stories you need to know about today.

Europe ‘At Epicentre’ of Pandemic Again

“Europe is at the epicentre of this pandemic once again,” was the latest message from Dr Hans Kluge, WHO regional director for Europe. “At the risk of sounding alarmist, I must express our very real concern and convey our steadfast commitment to stand beside you and support you as best we can.”

Yesterday, Europe exceeded the 10-million-case milestone.

Dr Kluge also spoke up for healthcare workers: “We have no COVID-19 response if we do not care for our healthcare and essential workers: their needs and well-being must be prioritised.”

France is back in national lockdown today. There was “no other solution” according to the country’s Prime Minister Jean Castex, Medscape’s French edition reported. Schools stay open but children have to wear masks.

Germany’s lockdown begins on Monday. Spain will be under a state of emergency until early May.

Preprint research from Switzerland suggests the strain of SARS-CoV-2 now circulating in the UK and many European countries originated in Spain.

The authors did not conclude whether tougher travel restrictions would have reduced the spread: “It is currently unclear whether this variant is spreading because of a transmission advantage of the virus or whether high incidence in Spain followed by dissemination through tourists is sufficient to explain the rapid rise in multiple countries.”

1 in 100 ‘Have Coronavirus’

The latest results from the Office for National Statistics (ONS) infection survey suggest 1 in 100 people in England have coronavirus. That’s around 568,100 people.

Infection rates were highest in the North West, and Yorkshire and the Humber.

ONS estimates there were around 9.52 new infections for every 10,000 people per day, or around 51,900 new cases a day.

In Wales 1 in 120 were estimated to have coronavirus. In Northern Ireland the figure was 1 in 80, and 1 in 140 in Scotland.

Katherine Kent from ONS said infections in the North East of England “appear to have now levelled off”.  

She added: “When looking at infections across different age groups, rates now seem to be steeply increasing among secondary school children whilst older teenagers and young adults continue to have the highest levels of infection.”

The UK’s R number is now 1.1-1.3 compared with 1.2-1.4 last week.

The growth rate is +2% to +4% per day.

In today’s daily data another 24,405 UK positive tests were reported and 274 deaths.

There are 10,708 COVID-19 patients in hospital and 975 ventilator beds are in use.

In the latest local lockdown changes in England, Calderdale, City of Bradford, Kirklees, Leeds and Wakefield move from the high tier to very high on Monday.

Did ‘Eat Out to Help Out’ Drive Up Infections?

The ‘Eat Out to Help Out’ restaurant subsidy scheme may have helped virus spreading as well as helping businesses, according to a University of Warwick working paper.

Researchers said a  ‘back of the envelope calculation’ shows that between 8% and 17% of the newly detected

Read more

Central Europe sounds alarm facing a shortages of medics as virus surges

KYJOV, Czech Republic (AP) — Soldiers in Poland are giving coronavirus tests. American National Guard troops with medical training are headed to the Czech Republic to work alongside doctors there. A Czech university student is running blood samples to labs, and the mayor of the capital is taking shifts at a hospital.

With cases surging in many central European countries, firefighters, students and retired doctors are being asked to help shore up buckling health care systems.

“This is actually terrifying,” Dr. Piotr Suwalski, the head of the cardiac surgery ward at a Polish hospital said on a day when daily COVID-19 cases rose 20% nationwide. “I think if we continue to gain 20% a day, no system can withstand it.”

Even before the pandemic, many countries in the region faced a tragic shortage of medical personnel due to years of underfunding in their public health sectors and an exodus of doctors and nurses to better paying jobs in Western Europe after the nations joined the European Union in 2004. Now, with the virus ripping through their hospitals, many health workers have been sickened, compounding the shortfall.

Over 13,200 medical personnel across the Czech Republic have been infected, including 6,000 nurses and 2,600 doctors, according to the doctors’ union.

It’s not just clinicians these countries need. Both Poland and the Czech Republic are building field hospitals as beds fill up on wards, and authorities say there are only 12 ventilators left in all hospitals taking COVID-19 patients in the region around Warsaw, the Polish capital.

This may sound familiar, but not for these countries. Many in the region imposed tough restrictions in the spring — including sealing borders and closing schools, stores and restaurants — and saw very low infection rates even as the virus killed tens of thousands in Western Europe.

READ MORE: France, Germany impose new lockdowns to curb virus spread

But now many central European countries are seeing an onslaught similar to the one their western neighbors experienced — and the same dire warnings.

As he announced new restrictions last week, Czech Prime Minister Andrej Babis put a date on when his country’s health system would collapse, if the new regulations were not imposed to slow the virus’s spread: between Nov. 7 and 11.

With one of the highest infection rates in Europe, the Czech Republic’s hospitals are desperately looking for volunteers. The government is deploying thousands of medical students to hospitals and other students to testing sites.

In the capital of Prague, Mayor Zdenek Hrib, who has a degree in medicine, volunteered to help do initial exams of possible coronavirus patients at a university hospital. Soon, 28 medical personnel from the Nebraska and Texas national guards are expected to arrive to help treat patients at Prague’s military hospital and a new field hospital at the city’s exhibition ground.

Croatia has asked former doctors to come out of retirement to help in hospitals, while Slovenia has put retired physicians and current medical students on standby in case its

Read more

A new coronavirus variant is seen spreading across Europe, research says

  • A new variant of the coronavirus, identified as 20A.EU1 by researchers from Switzerland and Spain, was first observed in Spain in June.
  • It has been recorded in Spain at frequencies of above 40% since July, the study said.
  • Elsewhere, the new variant of the coronavirus has increased from “very low” values prior to July 15 to 40% to 70% in Switzerland, Ireland, and the U.K. in September.
  • It was also found to be prevalent in Norway, Latvia, the Netherlands, and France.



a person walking down a street next to a building: A waiter sweeps the street of a tapas bar area near Elvira street on October 24, 2020 in Granada, Spain.


© Provided by CNBC
A waiter sweeps the street of a tapas bar area near Elvira street on October 24, 2020 in Granada, Spain.

LONDON — A variant of the coronavirus that is believed to have originated in Spain has spread across Europe and now accounts for most of the new cases reported in several countries in the region, according to the findings of a new study.

Loading...

Load Error

The research, which is due to published on Thursday and has not been peer reviewed, details how an international team of scientists has closely monitored the coronavirus through its genetic mutations.

Each variant of the coronavirus has its own genetic signature, meaning it can be traced back to the place it first emerged.

It says a new variant of the disease, identified as 20A.EU1 by researchers from Switzerland and Spain, was first observed in Spain in June. The new variant has been recorded in Spain at frequencies of above 40% since July, the study said.

Elsewhere, the new variant of the coronavirus has increased from “very low” values prior to July 15 to 40% to 70% in Switzerland, Ireland, and the U.K. in September. It was also found to be prevalent in Norway, Latvia, the Netherlands, and France.

New lockdowns will lead to ‘severe’ economic contractions, economist says, particularly in France

UP NEXT

UP NEXT

Researchers of the study said they had no direct evidence to suggest the new variant of the virus spreads faster than other mutations, despite the rise in frequency across multiple countries.

It also said there was currently no data to assess the severity of the disease, and while 20A.EU1 was dominant in some countries, it had not taken over everywhere and diverse variants of the coronavirus “continue to circulate across Europe.”

The authors of the study comprised of researchers from the University of Basel, the Biomedicine Institute of Valencia, and the University of Valencia, among others.

What are the implications?

The findings of the study indicate that people returning from vacations in Spain may have played a role in spreading the new variant of the virus across Europe.

It also raises questions about whether a recent upsurge in the number of new reported Covid-19 infections across the region could have been capped by stricter travel measures and improved screening at airports and other transport hubs.

“It is currently unclear whether this variant is spreading because of a transmission advantage of the virus or whether high incidence in Spain followed by dissemination through tourists is

Read more

Short of medics as virus surges, central Europe sounds alarm

KYJOV, Czech Republic (AP) — Soldiers in Poland are giving coronavirus tests. American National Guard troops with medical training are headed to the Czech Republic to work alongside doctors there. A Czech university student is running blood samples to labs, and the mayor of the capital is taking shifts at a hospital.

With cases surging in many central European countries, firefighters, students and retired doctors are being asked to help shore up buckling health care systems.

“This is actually terrifying,” Dr. Piotr Suwalski, the head of the cardiac surgery ward at a Polish hospital said on a day when daily COVID-19 cases rose 20% nationwide. “I think if we continue to gain 20% a day, no system can withstand it.”


Even before the pandemic, many countries in the region faced a tragic shortage of medical personnel due to years of underfunding in their public health sectors and an exodus of doctors and nurses to better paying jobs in Western Europe after the nations joined the European Union in 2004. Now, with the virus ripping through their hospitals, many health workers have been sickened, compounding the shortfall.

Over 13,200 medical personnel across the Czech Republic have been infected, including 6,000 nurses and 2,600 doctors, according to the doctors’ union.

It’s not just clinicians these countries need. Both Poland and the Czech Republic are building field hospitals as beds fill up on wards, and authorities say there are only 12 ventilators left in all hospitals taking COVID-19 patients in the region around Warsaw, the Polish capital.

This may sound familiar, but not for these countries. Many in the region imposed tough restrictions in the spring — including sealing borders and closing schools, stores and restaurants — and saw very low infection rates even as the virus killed tens of thousands in Western Europe.

But now many central European countries are seeing an onslaught similar to the one their western neighbors experienced — and the same dire warnings.

As he announced new restrictions last week, Czech Prime Minister Andrej Babis put a date on when his country’s health system would collapse, if the new regulations were not imposed to slow the virus’s spread: between Nov. 7 and 11.

With one of the highest infection rates in Europe, the Czech Republic’s hospitals are desperately looking for volunteers. The government is deploying thousands of medical students to hospitals and other students to testing sites.

In the capital of Prague, Mayor Zdenek Hrib, who has a degree in medicine, volunteered to help do initial exams of possible coronavirus patients at a university hospital. Soon, 28 medical personnel from the Nebraska and Texas national guards are expected to arrive to help treat patients at Prague’s military hospital and a new field hospital at the city’s exhibition ground.

Croatia has asked former doctors to come out of retirement to help in hospitals, while Slovenia has put retired physicians and current medical students on standby in case its situation deteriorates.

Poland, meanwhile, is mobilizing soldiers to conduct COVID-19 testing,

Read more

Nicox Granted New Patent for NCX 470, Extending Exclusivity in Europe to 2039

Press Release

Nicox Granted New Patent for NCX 470, Extending Exclusivity in Europe to 2039

 

October 29, 2020 – release at 7:30 am
Sophia Antipolis, France

 

Nicox SA (Euronext Paris: FR0013018124, COX), an international ophthalmology company, today announced that the European Patent Office has granted a formulation patent for NCX 470, extending the European exclusivity to 2039.  The equivalent U.S. patent has already been granted, and NCX 470 is also covered by granted composition of matter patents.

 

Gavin Spencer, Chief Business Officer at Nicox, said: “We are pleased that our formulation patent for NCX 470 has been granted in Europe, following the U.S. grant earlier in the year.  This strengthens our competitive position and provides further protection of this potential best-in-class product candidate for the lowering of intraocular pressure as we continue Phase 3 development and move it towards commercialization.

 

NCX 470, Nicox’s lead clinical product candidate, is a novel second-generation nitric oxide (NO)-donating bimatoprost analog for the lowering of intraocular pressure (IOP) in patients with open-angle glaucoma or ocular hypertension.  It is currently being evaluated in the Mont Blanc Phase 3 clinical trial which was initiated in the U.S. in June 2020 with top-line results currently expected in Q4 2021.  A second Phase 3 trial, Denali, is expected to start by the end of 2020, and will include clinical sites in both the U.S. and China, with the majority of the patients to be recruited in the U.S. 

 

NCX 470 is exclusively licensed to Ocumension Therapeutics for the Chinese, Korean and South East Asian markets.  The Denali trial is jointly funded by Nicox and Ocumension.

About NCX 470

NCX 470 is a novel, potential best-in-class, second generation nitric oxide (NO)-donating bimatoprost analog in development to reduce intraocular pressure (IOP) in patients with open-angle glaucoma or ocular hypertension.  Glaucoma is a group of ocular diseases in which the optic nerve is injured, leading to peripheral and, ultimately, central visual field loss and it can eventually lead to blindness if not treated. It is frequently linked to abnormally high IOP (~90% of patients) due to blockage or malfunction of the eye’s aqueous humor drainage system in the front of the eye.  In 2019, worldwide sales of treatments targeting glaucoma were over $6.0 billion out of a $21.9 billion worldwide market for ophthalmic drugs. 

NCX 470 is designed to release both bimatoprost and NO following instillation into the eye.  Bimatoprost, marketed under the brand name LUMIGAN® by Allergan, Inc., is one of the leading products in the class of prostaglandin analogs, the most widely used class of drugs for IOP-lowering in patients with open-angle glaucoma or ocular hypertension. 

About Nicox

Nicox S.A. is an international ophthalmology company developing innovative solutions to help maintain vision and improve ocular health.  Nicox’s lead program in clinical development is NCX 470, a novel, second-generation nitric oxide-donating bimatoprost analog, for lowering intraocular pressure in patients with glaucoma.  The company is also developing NCX 4251, a proprietary formulation of fluticasone, for acute exacerbations of blepharitis. 

Read more

Europe Anti-Viral Therapies Market Forecast to 2027

The Europe anti-viral therapies market is expected to reach US$ 21,122. 66 million by 2027 from US$ 11,401. 67 million in 2019; it is estimated to grow at a CAGR of 8. 1% during 2020–2027. The market is growth is primarily attributed to the increasing R&D expenditures in pharmaceutical companies and rising government support for research activities and clinical trials in Europe.

New York, Oct. 28, 2020 (GLOBE NEWSWIRE) — Reportlinker.com announces the release of the report “Europe Anti-Viral Therapies Market Forecast to 2027 – COVID-19 Impact and Regional Analysis By Type, Mechanism of Action, and Application, and Country” – https://www.reportlinker.com/p05978841/?utm_source=GNW
Additionally, strong pipeline of anti-viral drugs, and growing emphasis on launching anti-viral agents are likely to fuel the growth of the Europe anti-viral therapies market during the forecast period.

High cost of drug development is a key factor restraining the growth of the market.
Antiviral therapy is one of the most exciting branches of virology. These therapies are based on several strategies—direct-acting antivirals target viral proteins, enzymes, or nucleic acids; passive antibodies neutralize circulating viruses; and several other antivirals target cellular proteins or processes essential for viral replication.

Research and development (R&D) is an essential part of any business.Pharmaceutical companies focus on R&D to introduce new drugs with enhanced medical and commercial potential.

These companies invest majorly in R&D activities with an aim to deliver high-quality and innovative products in the market. As per the Association of the British Pharmaceutical Industry Pharmaceutical R&D expenditures grew by >11% in the UK in 2001, reaching an estimated US$ 5.23 billion. Johnson & Johnson, and Pfizer are among the top 10 leading R&D investing companies. The UK’s relative stability compared to the rest of Europe as a base for investment to an increase in R&D activity there by the three largest pharmaceutical investors. AstraZeneca, GlaxoSmithKline, and Pfizer collectively signify over 70% of total R&D spending in the UK, while other manufacturers with a significant presence in the country include Merck, Sharp & Dohme, Organon, Eli Lilly, and Novartis. Additionally, the pharma companies in the Germany are highly engaged in R&D activities.

Europe has witnessed exponential growth in the count of COVID-19 cases.Spain, Italy, Germany, France, and the UK are among the most affected European countries.

Growing research activities to develop treatment against corona virus is likely to favor the growth of the market in this region.In June 2020, the scientists from the University of Oxford tested existing drugs as therapies against this novel virus.

Further, the European Commission in July authorized the anti-viral drug Remdesivir for its use in the treatment of COVID-19 patients, making it the first approved drug in the European Union for the treatment.

In 2019, the branded drugs segment accounted for a larger share of the Europe antiviral therapies market.The branded antiviral drugs are more trusted than the generic drugs.

Further, robust research and development activities, increasing number of drug discoveries, and rising number of patents for drugs are the factors supporting the growth of this segment.

A

Read more

Europe Avocado Oil Market Forecast to 2027

The Europe avocado oil market is expected to grow from US$ 120. 30 million in 2018 to US$ 257. 05 million by 2027; it is estimated to grow at a CAGR of 8. 9% from 2019 to 2027. Avocado oil are perceived to be one of the healthiest ingredients which can be used in various food products such as bakery & confectionary, beverages, dairy & frozen desserts, and sweet & savory snacks.

New York, Oct. 28, 2020 (GLOBE NEWSWIRE) — Reportlinker.com announces the release of the report “Europe Avocado Oil Market Forecast to 2027 – COVID-19 Impact and Regional Analysis By Type, Nature, Variety, Application, and Distribution Channel” – https://www.reportlinker.com/p05978842/?utm_source=GNW
Avocado oil is gaining high popularity among the consumers due to rising awareness about the health benefits offered by avocado oil.

Avocado oil also has numerous benefits due to its high content of antioxidants and healthy fats.Various studies show that avocado oil benefits heart health and help in reducing blood pressure and blood cholesterol levels.

Avocado oil is a good source of lutein, a carotenoid that is naturally found in eyes.This nutrient improves eye health and also lowers the risk of age-related eye diseases.

Some nutrients need fat in order to be absorbed by the body. Therefore, rising awareness among the consumers about the health benefits of avocado oil is projected to boost its demand over the forecast period.
Based on variety, the Hass segment led the Europe avocado oil market in 2018.The Hass variety of avocado that has a dark green colored bumpy skin is the cultivar of avocado.

The Hass avocado is large, with weight ranging from 200 to 300 grams.When these avocados ripe, their skin turns into dark purplish-black and yields a gentle pressure.

It becomes white to green in the middle part of preparing the food and is ready to serve after the change of its color.The Hass avocado was first grown and sold by the southern California mail carrier and amateur horticulturist Rudolph Hass who later gave his name to these avocados.

Due to the taste, size, shelf-life, high growth yield, and year-round harvesting possibilities in some areas, the Hass variety is the most commercially popular avocado across the world. The Hass avocado trees flourish in the regions that have the right combination of abundant sunshine, mineral-rich soil, moderate humidity, warm days, and cool night.
In Europe, Italy is the hardest-hit country by the coronavirus outbreak.Italy recorded the highest number of coronavirus cases.

The country is expected to suffer an economic hit due to the lack of revenue from various industries.Other member states have implemented drastic measures and travel restrictions, including partially closing their borders.

This is anticipated to restrain the market growth in Europe. Many countries in Europe has issued and extended their lockdown period in order to sustain the virus.
The overall Europe avocado oil market size has been derived using both primary and secondary sources.To begin the research process, exhaustive secondary research has been conducted using internal and external sources to obtain

Read more

Europe and US facing new round of shutdowns amid virus surge

The resurgence and the resulting clampdown sent a shudder through Wall Street. The S&P 500 fell 3.5%, its biggest drop since June, and the Dow Jones Industrial Average lost 943 points, or 3.4%.

French President Emmanuel Macron declared a new nationwide lockdown starting Friday, saying the country has been “overpowered by a second wave.” Many doctors had urged the move, given that 58% of the nation’s intensive care units are now taken up by COVID-19 patients.

Countries such as Switzerland, Italy, Bulgaria and Greece have closed or otherwise clamped down again on nightspots and imposed other restrictions such as curfews and mandatory mask-wearing. Madrid and other parts of Spain banned all but essential travel in and out of their regions.

“We are deep in the second wave,” European Commission President Ursula von der Leyen said. “I think that this year’s Christmas will be a different Christmas.”

In the U.S., where practically every state is seeing a rise in cases, Democratic Gov. Tony Evers of hard-hit Wisconsin has been reduced to pleading with people to stay home, after an order he issued in the spring was overturned by the courts. Illinois’ governor banned indoor dining and drinking in Chicago this week. Other states are likewise considering reimposing restrictions.

The virus has killed more than 250,000 people in Europe and over 227,000 in the U.S., according to the count kept by Johns Hopkins University.

The long-feared surge is blamed in part on growing disregard for social distancing and mask-wearing, as well as the onset of cold weather, which is forcing people indoors, where the virus can spread more easily.

Dr. David Letzer, an infectious-disease specialist who doubles as chairman of the Wisconsin Medical Society’s COVID-19 task force, is getting swamped with patients. He said he was incensed to see people without masks going into a restaurant as he was driving between hospitals.

“I’m just coming from a place with ventilators and people are just going to an indoor restaurant,” he said. “Those are the things that are frustrating and take their toll.”

In the U.S., more than 71,000 people a day are testing positive on average, up from 51,000 two weeks ago. Cases are on the rise in all but two states, Hawaii and Delaware, and deaths are climbing in 39 states, with an average of 805 people dying in the U.S. per day, up from 714 two weeks ago.

Wisconsin, one of the worst hot spots of them all, set records Tuesday for the number of daily infections at nearly 5,300 and deaths with 64. About 12% of the state’s intensive care beds were

Read more
  • Partner links